Bitcoin's pullback opens a buy-the-dip chance in IBKR, HOOD and PYPL as rate cut hopes fuel optimism.

RADNOR, Pa. , Aug. 29, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of BellRing Brands, Inc. (NYSE: BRBR) ("BellRing Brands").

RADNOR, Pa., Aug. 29, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Fortinet, Inc. (NASDAQ: FTNT) (“Fortinet”).

NEW YORK--(BUSINESS WIRE)---- $WOOF #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) and reminds investors of the August 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California an.

The company's cloud-intelligence business was the fastest-growing segment, increasing revenues 26% year over year.

Peloton has executed a significant turnaround, producing positive free cash flow, paying down debt, and stabilizing margins after a dramatic post-pandemic decline. Management's bold new vision aims to expand Peloton from cardio fitness into a full-spectrum wellness platform, targeting mental health, sleep, and nutrition. Despite the progress, Peloton trades at just 9x free cash flow, offering compelling asymmetric upside versus current market valuations.

Supervielle delivered strong loan growth (+71% YoY real) and a rebound in net interest margin to 20.8%, showing operational progress despite high rates. Net income improved to AR$13.6B with ROAE back to 5.8%, but profitability remains well below peers like Galicia and BBVA. Provisions surged 173% YoY and efficiency weakened to 60.9%, highlighting the cost of focusing on consumer credit and digital expansion.

The Direxion Daily Healthcare Bull 3X Shares ETF tracks an index composed of U.S. healthcare stocks. While the healthcare sector as a whole is essentially flat in 2025, the effect of beta slippage and a high expense ratio has resulted in CURE underperforming unleveraged ETFs. Looking ahead, CURE's underlying index trades at just 17.3x its forward earnings estimates, a wide discount relative to the S&P 500.

CNQ, CVX and KMI present an opportunity for long-term stability and reliable returns in the volatile energy space.

MU and IBM are tapping AI-driven demand with strong growth prospects, estimate upgrades and notable upside potential.

FCX pushes forward with major expansion projects, green energy shifts, and rising earnings outlook to fuel long-term growth.

Raymond James analyst Tim Thein cut his earnings targets for Caterpillar after the bulldozer maker bumped up its cost estimates for tariffs.

Looking to add some diversification and upside to your equities allocation? While the broader tech space has largely relied on just a handful of names, smaller subcategories in innovative tech also have a role to play.

European nations are recognizing they need to commit more capital to defense. Therefore,related spending is surging around the world.

With an eye on mitigating rate risk, short-term bond funds have been the apple of fixed income investors' eyes the past few years. But with rates falling, those same eyes may be wandering and looking at long-term bond ETFs.

Key Points in This Article: Ethereum (ETH) is seeing massive ETF inflows, surpassing Bitcoin (BTC), with $1.5 billion in a week compared to Bitcoin's $244 million.

Palantir (NASDAQ:PLTR ) is Wall Street's latest darling, and it could end up being the greatest if it continues on this trajectory.

As a smart investor, can you really cover all of your bases with just four exchange traded funds (ETFs)?

Freeport and Southern Copper face copper price swings, but both push ahead with major projects leveraging strong cash flows.

Intel's foundry struggles and market share losses persist, but new CEO Lip-Bu brings a more realistic and disciplined approach to challenges. Intel's Q2 earnings beat revenue expectations but were weighed down by significant one-time restructuring and impairment charges, reflecting ongoing operational issues. The U.S. government taking a 10% equity stake signals political support, potentially ensuring the foundry business's survival despite financial dilution concerns.